Xrec2 DNS und Polypeptide

Patent europeic · EP1690871 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1690871
Numer da la dumonda
EP05025531
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-12-1999
Publitgà
16-08-2006
Concedì
15-04-2009
Stritgà
31-12-2014
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/47 (2006.01)
Prioritad
US 112163 P 14.12.1998
US 164675 P 10.11.1999
Derivà da
EP99966182
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-07-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.07.2015

  2. 17-06-2009

    Represchentant inscrit

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 324, 1226 Geneve-Thônex

    Published in Swissreg on 17.06.2009

  3. 15-04-2009

    Concedì

    Published in Swissreg on 15.04.2009

Partidas

Possessur

Immunex Corporation

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Represchentant

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 324, 1226 Geneve-Thônex

Inventur

Sims, John E.

Seattle, WA 98105, US

Smith, Dirk E.

Bainbridge Island, WA 98110, US

Born, Teresa L.

Kenmore, WA 98028, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.